Medscape September 12, 2023
TOPLINE:
In an online survey of 605 people with diabetes who use insulin and continuous glucose monitors (CGMs), a majority expressed satisfaction with many aspects of the devices’ performance. However, significant proportions also reported concerns about accuracy under certain circumstances, and about skin problems.
METHODOLOGY:
Researchers did an online survey of 504 people with type 1 diabetes from the T1D Exchange and 101 with type 2 diabetes from the Dynata database.
TAKEAWAY:
The Dexcom G6 device was used by 60.7% of all current CGM users, including 69% of those with type 1 diabetes vs 12% with type 2 diabetes.
People with type 2 diabetes were more likely to use older Dexcom versions (G4/G5) (32%) or Abbott’s...